Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114478375A reveals a novel Pd-catalyzed route to 3-alkenyl quinolin-2(1H)ones using allyl aryl ethers, offering safer carbonylation and cost reduction in API manufacturing.
Patent CN113636968B details a Ru-catalyzed hydrogen transfer method for 3-acylpyrroles, offering high atom economy and simplified purification for pharmaceutical intermediates.
Patent CN114195726B details a novel CuCl-catalyzed route for trifluoromethyl triazoles. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for API manufacturers.
Novel chiral phosphoric acid catalysis enables high-yield indoline pyrrole synthesis. Cost-effective scalable production for pharmaceutical intermediates supply chain.
Patent CN108864164B details a green Pd-catalyzed method for 2-alkynyl indoles using water solvent, offering cost-effective pharma intermediate manufacturing.
Patent CN113980028A details a mild, scalable method for chiral spiro indolones using cinchona alkaloid catalysts, offering high stereoselectivity for pharmaceutical intermediates.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high yields and simplified supply chains for API intermediates.
Novel Rh(III)-catalyzed C-H activation route for C2-sulfonamido indoles. Optimized process offers significant cost reduction in API manufacturing and simplified purification.
Patent CN115215810B reveals catalyst-free synthesis for high-purity triazoles. Enables cost reduction and scalable supply chain for pharmaceutical intermediate manufacturing globally.
Novel FeCl3-catalyzed route offers high yields and scalability for drug discovery, reducing costs in pharmaceutical intermediate manufacturing.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN114163436A details a Pd-catalyzed route for indolizine-diarylmethanes. Delivers high-purity API intermediates with scalable cost reduction strategies.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN115215810B reveals catalyst-free synthesis for trifluoromethyl triazoles. Enables cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN118126005B reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction in fine chemical manufacturing with scalable air atmosphere reactions.
Patent CN113045503B reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering high yields and scalable API intermediate manufacturing.
Novel nickel-catalyzed method for 2-pyrrolidone derivatives offers cost-effective scalable synthesis for pharmaceutical intermediates supply chain optimization and high purity standards.